Level Financial Advisors, Inc. My Md Pharmaceuticals, Inc. Transaction History

Level Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	BUY	$0.47 - $1.87 $94 - $374	200 Added 100.0%	400 $0
Q2 2022 Jul 19, 2022	BUY	$2.0 - $4.78 $400 - $956	200 New	200 $1,000
Q1 2022 Apr 08, 2022	SELL	$3.34 - $6.05 $668 - $1,210	-200 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$5.46 - $9.69 $1,092 - $1,938	200 New	200 $1,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Level Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Level Financial Advisors, Inc. with notifications on news.